Literature DB >> 11945001

Experimental Nipah virus infection in pigs and cats.

D J Middleton1, H A Westbury, C J Morrissy, B M van der Heide, G M Russell, M A Braun, A D Hyatt.   

Abstract

A human isolate of Nipah virus from an outbreak of febrile encephalitis in Malaysia that coincided with a field outbreak of disease in pigs was used to infect eight 6-week-old pigs orally or subcutaneously and two cats oronasally. In pigs, the virus induced a respiratory and neurological syndrome consistent with that observed in the Malaysian pigs. Not all the pigs showed clinical signs, but Nipah virus was recovered from the nose and oropharynx of both clinically and sub-clinically infected animals. Natural infection of in-contact pigs, which was readily demonstrated, appeared to be acute and self-limiting. Subclinical infections occurred in both inoculated and in-contact pigs. Respiratory and neurological disease was also produced in the cats, with recovery of virus from urine as well as from the oropharynx. The clinical and pathological syndrome induced by Nipah virus in cats was comparable with that associated with Hendra virus infection in this species, except that in fatal infection with Nipah virus there was extensive inflammation of the respiratory epithelium, associated with the presence of viral antigen. Viral shedding via the nasopharynx, as observed in pigs and cats in the present study, was not a regular feature of earlier reports of experimental Hendra virus infection in cats and horses. The findings indicate the possibility of field transmission of Nipah virus between pigs via respiratory and oropharyngeal secretions. Copyright Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 11945001     DOI: 10.1053/jcpa.2001.0532

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  85 in total

Review 1.  The immune response to Nipah virus infection.

Authors:  Joseph Prescott; Emmie de Wit; Heinz Feldmann; Vincent J Munster
Journal:  Arch Virol       Date:  2012-06-06       Impact factor: 2.574

2.  Antibody prophylaxis and therapy against Nipah virus infection in hamsters.

Authors:  V Guillaume; H Contamin; P Loth; I Grosjean; M C Georges Courbot; V Deubel; R Buckland; T F Wild
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Recombinant nipah virus vaccines protect pigs against challenge.

Authors:  Hana M Weingartl; Yohannes Berhane; Jeff L Caswell; Sheena Loosmore; Jean-Christophe Audonnet; James A Roth; Markus Czub
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.

Authors:  Matthew I Bonaparte; Antony S Dimitrov; Katharine N Bossart; Gary Crameri; Bruce A Mungall; Kimberly A Bishop; Vidita Choudhry; Dimiter S Dimitrov; Lin-Fa Wang; Bryan T Eaton; Christopher C Broder
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-05       Impact factor: 11.205

5.  A single amino acid substitution in the V protein of Nipah virus alters its ability to block interferon signalling in cells from different species.

Authors:  Kathrin Hagmaier; Nicola Stock; Steve Goodbourn; Lin-Fa Wang; Richard Randall
Journal:  J Gen Virol       Date:  2006-12       Impact factor: 3.891

6.  Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.

Authors:  Thomas W Geisbert; Kathleen M Daddario-DiCaprio; Andrew C Hickey; Mark A Smith; Yee-Peng Chan; Lin-Fa Wang; Joseph J Mattapallil; Joan B Geisbert; Katharine N Bossart; Christopher C Broder
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

7.  A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.

Authors:  Katharine N Bossart; Zhongyu Zhu; Deborah Middleton; Jessica Klippel; Gary Crameri; John Bingham; Jennifer A McEachern; Diane Green; Timothy J Hancock; Yee-Peng Chan; Andrew C Hickey; Dimiter S Dimitrov; Lin-Fa Wang; Christopher C Broder
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

8.  Nipah virus infection and glycoprotein targeting in endothelial cells.

Authors:  Stephanie Erbar; Andrea Maisner
Journal:  Virol J       Date:  2010-11-08       Impact factor: 4.099

9.  Transmission of human infection with Nipah virus.

Authors:  Stephen P Luby; Emily S Gurley; M Jahangir Hossain
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

10.  Targeted strategies for henipavirus therapeutics.

Authors:  Katharine N Bossart; John Bingham; Deborah Middleton
Journal:  Open Virol J       Date:  2007-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.